Organigram Earnings: Canaccord Raises Target While Others Cut
On April 13th, Organigram Holdings (TSX: OGI) (NASDAQ: OGI) reported their second fiscal quarter for 2021. Revenue for the quarter
Read moreOn April 13th, Organigram Holdings (TSX: OGI) (NASDAQ: OGI) reported their second fiscal quarter for 2021. Revenue for the quarter
Read moreRevenues continue to decline for Organigram Holdings (TSX: OGI) (NASDAQ: OGI). The company this morning posted net revenues for the
Read moreThe upcoming week is going to be a busy one, as markets await first quarter earnings from a number of
Read moreOrganigram Holdings (TSX: OGI) (NASDAQ: OGI) will be reporting their fiscal second quarter on April 13th before the market open.
Read moreOn April 6th, Organigram Holdings (TSX: OGI) (NASDAQ: OGI) announced that they acquired cannabis 2.0 operator The Edibles & Infusions
Read moreOrganigram Holdings (TSX: OGI) (NASDAQ: OGI) on Thursday quietly announced that they had repaid outstanding facilities with the Bank of
Read moreOn March 9th, Organigram Holdings (TSX: OGI) (NASDAQ: OGI) announced that they received a C$221 million strategic investment from British
Read moreOrganigram Holdings (TSX: OGI) (NASDAQ: OGI) has seen a strategic investment from that of BAT (NYSE: BTI), whom is more
Read moreOrganigram Holdings (TSX: OGI) (NASDAQ: OGI) yesterday morning reported its first-quarter 2021 financial results for the period ended November 30,
Read moreOrganigram Holdings (TSX: OGI) (NASDAQ: OGI) this morning reported its first quarter 2021 financial results for the period ended November
Read more